Wright Medical Group NV (NASDAQ:WMGI) Director Sells $520,210.47 in Stock
Wright Medical Group NV (NASDAQ:WMGI) Director Kevin C. Oboyle sold 17,277 shares of the firm’s stock in a transaction that occurred on Tuesday, November 13th. The stock was sold at an average price of $30.11, for a total transaction of $520,210.47. The sale was disclosed in a document filed with the SEC, which is accessible through this link.
Shares of WMGI stock traded down $0.48 during mid-day trading on Friday, reaching $26.49. The company’s stock had a trading volume of 1,200,041 shares, compared to its average volume of 1,268,242. Wright Medical Group NV has a 12-month low of $19.01 and a 12-month high of $30.75. The company has a current ratio of 1.24, a quick ratio of 1.07 and a debt-to-equity ratio of 0.61. The company has a market cap of $3.37 billion, a PE ratio of -120.41 and a beta of 1.15.
Wright Medical Group (NASDAQ:WMGI) last issued its earnings results on Wednesday, November 7th. The medical device company reported ($0.09) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.15) by $0.06. Wright Medical Group had a negative net margin of 13.07% and a negative return on equity of 0.60%. The business had revenue of $194.11 million for the quarter, compared to the consensus estimate of $186.09 million. During the same quarter last year, the firm posted ($0.16) EPS. The business’s revenue for the quarter was up 13.8% compared to the same quarter last year. Equities research analysts expect that Wright Medical Group NV will post -0.07 EPS for the current fiscal year.
WMGI has been the topic of a number of recent analyst reports. Jefferies Financial Group increased their price target on shares of Wright Medical Group from $31.00 to $35.00 and gave the stock a “buy” rating in a research note on Thursday, November 8th. Needham & Company LLC increased their price target on shares of Wright Medical Group from $30.00 to $35.00 and gave the stock a “buy” rating in a research note on Thursday, October 25th. BidaskClub raised shares of Wright Medical Group from a “hold” rating to a “buy” rating in a research note on Friday, October 19th. ValuEngine raised shares of Wright Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, September 19th. Finally, Stifel Nicolaus initiated coverage on shares of Wright Medical Group in a research note on Tuesday, August 21st. They set a “buy” rating and a $34.00 price target on the stock. Three investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $32.62.
ILLEGAL ACTIVITY NOTICE: “Wright Medical Group NV (NASDAQ:WMGI) Director Sells $520,210.47 in Stock” was first posted by Marea Informative and is the property of of Marea Informative. If you are viewing this story on another site, it was illegally stolen and reposted in violation of international copyright and trademark legislation. The original version of this story can be viewed at https://www.mareainformativa.com/news/2018/12/08/kevin-c-oboyle-sells-17277-shares-of-wright-medical-group-nv-wmgi-stock-updated-updated-updated.html.
Wright Medical Group Company Profile
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells extremities and biologics products. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.
Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.